Sofinnova Investments, Inc. Immunovant, Inc. Transaction History

Sofinnova Investments, Inc.

  • $1.06 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 15, 2024
BUY
$31.31 - $44.19 $6.97 Million - $9.83 Million
222,553 New
222,553 $9.38 Million
Q4 2023

Feb 12, 2024
BUY
$31.31 - $44.19 $6.97 Million - $9.83 Million
222,553 New
222,553 $9.38 Million
Q3 2020

Nov 13, 2020
SELL
$22.61 - $38.9 $915,998 - $1.58 Million
-40,513 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$13.87 - $28.44 $561,915 - $1.15 Million
40,513 New
40,513 $987,000

Others Institutions Holding IMVT

# of Institutions
212
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email